iShares U.S. Pharmaceuticals ETF (IHE)
| 181.22 Delayed Data As of May 07 |  +1.14 / +0.63%Today’s Change | 145.27 Today|||52-Week Range 188.10 | +0.99% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.
Latest IHE News
| Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? May 07 / Zacks.com - Paid Partner Content |
Performance
| 1 month | +3.43% | 3 years | +9.95% | |
| 3 months | -0.68% | 5 years | +7.62% | |
| 1 year | +22.66% | Since inception | +10.49% |
Data through 05/08/2021
Quote Details
| Previous close | $180.08 |
| Open day’s range | 181.22 – 181.88 |
| Net asset value (NAV) | 181.14 (05/07/2021) |
| Daily volume | 2,864 |
| Average volume (3 months) | 7,901 |
Data as of 3:59pm ET, 05/07/2021
Peer Comparisonvs. Health ETFs
| IHE | Category | |
|---|---|---|
| Performance 5-yr return | +7.62% | +15.28% |
| Expense Gross exp ratio | 0.42% | 1.03% |
| Risk 5 year sharpe ratio | 0.38 | 0.80 |
| Net assets | $358.3M | $2.5B |
| Average market cap | $59.0B | $31.0B |
| Average P/E | 29.8 | 28.0 |
| Dividend / Share | -- | 0.29% |
Competitors
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 98.99% |
| Consumer goods | 1.01% |
| Business service | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 22.65% |
| PFE Pfizer | 18.52% |
| MRK Merck | 5.39% |
| ZTS Zoetis Inc | 5.07% |
| CTLT Catalent Inc | 4.84% |
| HZNP Horizon Therapeutics PLC | 4.70% |
| BMY Bristol-Myers Squibb | 4.54% |
| ELAN Elanco Animal Health Inc | 4.29% |
| VTRS Viatris Inc | 4.19% |
| LLY Eli Lilly and Co | 3.94% |
